英文字典中文字典Word104.com

中文字典辭典英文字典 a b c d e f g h i j k l m n o p q r s t u v w x y z

mesoblast

n. 中胚葉

中胚葉

WordNet (r) 3.0 (2006) (WordNet)

mesoblast
n 1: the middle germ layer that develops into muscle and bone
and cartilage and blood and connective tissue [synonym:
{mesoderm}, {mesoblast}]

The Collaborative International Dictionary of English v.0.48 (gcide)

Mesoblast \Mes"o*blast\, n. [Meso- -blast.] (Biol.)
(a) The mesoderm.
(b) The cell nucleus; mesoplast.
[1913 Webster]

請選擇你想看的字典辭典：

單詞	字典	翻譯
Mesoblast	查看　Mesoblast　在Google字典中的解釋	Google英翻中〔查看〕
Mesoblast	查看　Mesoblast　在Yahoo字典中的解釋	Yahoo英翻中〔查看〕

安裝中文字典英文字典查詢工具!

中文字典英文字典工具:

選擇顏色:

<style type="text/css">#word104_1 br {display:none;}</style>
<form id="word104_1" method="post" action="http://www.word104.com/index.php" target="_blank">
<div style="width: 140px;border:1px solid #000;background-color:#ffffff;padding: 0px 0px;margin: 0px 0px;align:center;text-align:center;overflow:hidden;"><div id="xcolor1_1" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://www.word104.com/" alt="英文字典中文字典" title="英文字典中文字典" id="word_name104_1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" >英文字典中文字典</a></div><table width=100% style='align:center;text-align:left;font-size:12px;background-color:#ffffff;color:#333333;'>
<tr><td style="text-align:center;border:0"><input type=hidden name="word104_hi" value="1">輸入中英文單字</td></tr><tr><td style="text-align:center;border:0"><input type="text" name="word104_input" value="" size=10 style="background-color:#ffffff;color:#000;text-decoration:none;font-family: arial;rial;border:1px solid #999;padding:1px!important;"></td></tr><tr style='line-height: 26px;'><td style="text-align:center;border:0"><input type=submit style="background-color:#ccc;color:#000;border:0 none;cursor:pointer;" value="查詢字典"></td></tr></table></div>
</form>

英文字典中文字典相關資料:

INVESTORS MEDIA HOME - Mesoblast
The Investor Relations website contains information about Mesoblast's business for stockholders, potential investors, and financial analysts
Mesoblast - Wikipedia
Mesoblast Limited is an Australian regenerative medicine company It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain
Mesoblast finally pushes GvHD cell therapy over finish line
Mesoblast has secured FDA approval for the first-ever mesenchymal stem cell (MSC) therapy, Ryoncil for acute GvHD in children undergoing HSCT
Mesoblast Limited (MESO) - Yahoo Finance
Find the latest Mesoblast Limited (MESO) stock quote, history, news and other vital information to help you with your stock trading and investing
After two rejections, FDA approves Mesoblasts GVHD cell therapy
After two rejections from the FDA, Mesoblast has finally gained approval for its first drug, Ryoncil, a cell therapy for graft versus host disease
Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform . . . - BioSpace
Mesoblast (the Company) is a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions
Long-awaited FDA approval for Mesoblast marks a first in . . . - BioCentury
At long last, Mesoblast has gained its first FDA approval — nearly a decade after Japan’s regulatory agency approved the same product, an allogeneic bone marrow-derived mesenchymal stromal cell therapy for GvHD
Mesoblast: First FDA-Approved MSC Drug Ryoncil Drives 191% Revenue . . .
Mesoblast (NASDAQ:MESO) reported significant achievements for FY2025, highlighted by the FDA approval and successful launch of Ryoncil®, the first FDA-approved MSC therapy in the US for steroid-refractory acute graft-versus-host disease in pediatric patients
US FDA approves Mesoblasts cell therapy for graft-versus-host disease
The U S Food and Drug Administration on Wednesday approved Mesoblast's cell therapy for treating a type of complication that occurs after a stem cell or bone marrow transplant called
Mesoblast, A Top 1% Biotech, Skyrockets On FDA Approval In Graft Versus . . .
Mesoblast (MESO) snagged Food and Drug Administration approval for the first-ever treatment for children with a form of graft vs host disease The top-notch biotech stock rocketed Thursday

中文字典-英文字典 2005-2009

|中文姓名英譯,姓名翻譯 |简体中文英文字典